← Leaderboards
Rebeca Rico-Hesse
Univ Of Massachusetts Med Sch Worcester
$9,529,170
Attributed
$9,529,170
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$9,529,170 · 4
By mechanism
R01$9,085,477 · 3
P01$443,693 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Sharone Green$10,022,553
- Francis Anthony Ennis$2,726,792
- Daniel H. Libraty$9,037,594
- Robert Thomas Woodland$5,789,549
- Eva Szomolanyi-Tsuda$2,849,455
Others in their field
Top investigators on “Dengue Virus”
- Eva Harris · University Of California Berkeley$37,686,458
- Scott C Weaver · University Of Texas Medical Br Galveston$35,108,137
- Daniel F. Hoft · Saint Louis University$26,271,892
- Aravinda M De Silva · University Of North Carolina Chapel Hill$25,826,251
- Urban Ramstedt · Abviro, Llc$25,767,897
- Michael S. Diamond · University Of Pittsburgh At Pittsburgh$25,356,653
Research focus
Dengue VirusVirulenceGenotypeDengueVirusAsian AmericansPathogenTransmission ProcessViralVaccinesSerotypingInfectionCategoriesMouse ModelCulicidaeIn VivoNational Institute Of Allergy And Infectious DiseaseVirus ReplicationTissue /Cell CultureFosteringGenomeExanthemaBiteFlavivirus
Grant awards (22)
Mosquito Saliva in Dengue Virus Pathogenesis$491,188
R01 · FY2017 · AI · contact PI
Mosquito Saliva in Dengue Virus Pathogenesis$598,459
R01 · FY2016 · AI · contact PI
Therapy of Dengue with Modified Antibodies in Humanized Mice$661,840
R01 · FY2015 · AI · contact PI
Mosquito Saliva in Dengue Virus Pathogenesis$612,584
R01 · FY2015 · AI · contact PI
Therapy of Dengue with Modified Antibodies in Humanized Mice$723,876
R01 · FY2014 · AI · contact PI
Mosquito Saliva in Dengue Virus Pathogenesis$464,058
R01 · FY2014 · AI · contact PI
Therapy of Dengue with Modified Antibodies in Humanized Mice$680,444
R01 · FY2013 · AI · contact PI
Mosquito Saliva in Dengue Virus Pathogenesis$451,173
R01 · FY2013 · AI · contact PI
Therapy of Dengue with Modified Antibodies in Humanized Mice$600,433
R01 · FY2012 · AI · contact PI
Therapy of Dengue with Modified Antibodies in Humanized Mice$183,697
R01 · FY2012 · AI · contact PI
Dengue Virus Determinants of Virulence and Transmission$489,629
R01 · FY2009 · AI · contact PI
Dengue Virus Determinants of Virulence and Transmission$407,216
R01 · FY2008 · AI · contact PI
Dengue Virus Determinants of Virulence and Transmission$402,965
R01 · FY2007 · AI · contact PI
Dengue Virus Determinants of Virulence and Transmission$415,000
R01 · FY2006 · AI · contact PI
Dengue Virus Determinants of Virulence and Transmission$388,350
R01 · FY2005 · AI
Dengue Virus Determinants of Virulence and Transmission$388,350
R01 · FY2004 · AI
Dengue Virus Determinants of Virulence and Transmission$388,350
R01 · FY2003 · AI
Dengue Virus Determinants of Virulence and Transmission$388,350
R01 · FY2002 · AI
VIRAL DETERMINANTS OF SEVERE DENGUE DISEASE$167,178
P01 · FY2002 · AI
Dengue Virus Determinants of Virulence and Transmission$349,515
R01 · FY2001 · AI
VIRAL DETERMINANTS OF SEVERE DENGUE DISEASE$0
P01 · FY2001 · AI
VIRAL DETERMINANTS OF SEVERE DENGUE DISEASE$276,515
P01 · FY2000 · AI